Ralliant Corporation (NYSE:RAL) to Issue Quarterly Dividend of $0.05

Ralliant Corporation (NYSE:RAL) announced a quarterly dividend on Tuesday, August 4th. Investors of record on Tuesday, September 8th will be paid a dividend of 0.05 per share on Wednesday, September 23rd. This represents a c) dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Tuesday, September 8th.

Ralliant Price Performance

Ralliant stock opened at $67.13 on Wednesday. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.75. The company has a 50-day moving average price of $67.37 and a 200 day moving average price of $54.54. Ralliant has a 12-month low of $37.27 and a 12-month high of $75.41. The stock has a market cap of $7.43 billion, a P/E ratio of -6.19, a PEG ratio of 2.42 and a beta of 1.60.

Ralliant (NYSE:RAL) last posted its earnings results on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, beating the consensus estimate of $0.63 by $0.05. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. The company had revenue of $567.80 million for the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. Sell-side analysts anticipate that Ralliant will post 2.87 earnings per share for the current year.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.